Eikenboom J C, Matsushita T, Reitsma P H, Tuley E A, Castaman G, Briët E, Sadler J E
Department of Hematology, University Hospital, Leiden, The Netherlands.
Blood. 1996 Oct 1;88(7):2433-41.
No defects have been reported in moderately severe type 1 von Willebrand disease (vWD) with a clear autosomal dominant inheritance pattern, and the mechanism underlying this form of vWD remains obscure. We have studied a type 1 vWD family with such a dominant phenotype. The entire coding sequence of the von Willebrand factor (vWF) gene was analyzed by direct sequencing of DNA fragments amplified by polymerase chain reaction. Only one candidate mutation T(3445)-->C in exon 26 was detected that predicts a replacement of cysteine (C) at position 386 of the mature vWF subunit by arginine (R). Both mutant and normal vWF alleles were expressed as shown by analysis of platelet mRNA. This substitution segregates with vWD in the family and was not found in 100 unrelated individuals. The recombinant mutant vWF(C386R) was characterized by expression in 293T cells. The secretion of vWF(C386R) was greatly impaired due to retention in the endoplasmic reticulum. In cotransfections of normal and mutant vWF constructs, the vWF(C386R) subunits caused a dose-dependent decrease in the secretion of vWF. The multimer pattern remained nearly normal and consistent with a dominant vWD type 1 phenotype. The importance of the cysteine residues in the D3 domain of vWF in the pathogenesis of dominant type 1 vWD was further shown by the detection of another cysteine mutation, Cys367-->Phe, in two additional unrelated patients with a similar dominant type 1 vWD phenotype. We conclude that the loss of cysteine pairing in the D3 domain, leaving one free cysteine, can induce a purely quantitative deficiency of vWF by dominantly suppressing the secretion of normal vWF.
中度严重的1型血管性血友病(vWD)具有明确的常染色体显性遗传模式,尚未有缺陷报道,这种形式的vWD的潜在机制仍不清楚。我们研究了一个具有这种显性表型的1型vWD家族。通过对聚合酶链反应扩增的DNA片段进行直接测序,分析了血管性血友病因子(vWF)基因的整个编码序列。仅检测到一个候选突变,即外显子26中的T(3445)-->C,该突变预测成熟vWF亚基第386位的半胱氨酸(C)被精氨酸(R)取代。通过对血小板mRNA的分析表明,突变型和正常vWF等位基因均有表达。这种替代在家族中与vWD共分离,在100名无关个体中未发现。重组突变体vWF(C386R)通过在293T细胞中表达进行表征。由于在内质网中滞留,vWF(C386R)的分泌受到极大损害。在正常和突变vWF构建体的共转染中,vWF(C386R)亚基导致vWF分泌呈剂量依赖性减少。多聚体模式几乎保持正常,与显性1型vWD表型一致。在另外两名具有相似显性1型vWD表型的无关患者中检测到另一个半胱氨酸突变Cys367-->Phe,进一步证明了vWF D3结构域中的半胱氨酸残基在显性1型vWD发病机制中的重要性。我们得出结论,D3结构域中半胱氨酸配对的丧失,留下一个游离半胱氨酸,可通过显性抑制正常vWF的分泌诱导vWF的单纯定量缺乏。